Home > Insider Trading > Filing (0001209191-15-064675)

Filing Details

Accession Number:: 0001209191-15-064675
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-08-07 17:08:15
Reporting Period:: 2015-08-06

Filing Date:: 2015-08-07
Accepted Time:: 2015-08-07 17:08:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
860730	Hca Holdings Inc.	HCA	Services-General Medical & Surgical Hospitals, Nec (8062)	273865930

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1216856	A Robert Waterman	One Park Plaza Nashville TN 37203	Svp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-08-06	60,429	$5.31	552,748	No	4	M	Direct
Common Stock	Acquisiton	2015-08-06	149,175	$11.32	701,923	No	4	M	Direct
Common Stock	Disposition	2015-08-06	145,302	$91.23	556,621	No	4	S	Direct
Common Stock	Disposition	2015-08-06	49,803	$92.23	506,818	No	4	S	Direct
Common Stock	Disposition	2015-08-06	14,499	$92.82	492,319	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2015-08-06	60,006	$0.00	60,006	$5.31
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2015-08-06	423	$0.00	423	$5.31
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2015-08-06	90,009	$0.00	90,009	$11.32
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2015-08-06	59,166	$0.00	59,166	$11.32

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2017-01-30	No	4	M	Direct
59,588	2017-01-30	No	4	M	Direct
0	2017-01-30	No	4	M	Direct
0	2017-01-30	No	4	M	Direct

Footnotes

The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2015.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.745 to $92.72, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.74 to $93.04, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
The option vested in equal increments at the end of fiscal years 2010 and 2011 based upon the achievement of certain annual EBITDA performance targets.
Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
The option vested in two equal annual installments beginning on January 30, 2011.
The option vested in three equal annual installments beginning on January 30, 2008.
The option vested in equal increments at the end of fiscal years 2007, 2008, and 2009 based upon the achievement of certain annual EBITDA performance targets.